Report initial data on bivalent booster candidate mRNA-1273.214
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 4 May 2022
- Due
- 30 Jun 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The Company expects initial data on mRNA-1273.214 in June to inform selection of its candidate for the Northern Hemisphere fall 2022 booster.”
What we found
Evidence strength A What the grades mean
A August 2022 10-Q reports June 2022 clinical data for mRNA-1273.214 meeting all pre-specified endpoints, consistent with initial data being reported in June.
-
A Moderna 8-K filed 2022-08-03
“Positive data on booster dose of bivalent candidate based on the wild-type and Omicron subvariant BA.1 (mRNA-1273.214)” ✓ confirmed on the page
-
A Moderna 10-Q filed 2022-08-03
“Based on our June 2022 clinical data, a 50 µg booster dose of mRNA-1273.214 met all pre-specified endpoints including superior neutralizing antibody response (geometric mean ratio) against the Omicron variant” ✓ confirmed on the page
Market reaction: the shares moved +14.9% against the S&P 500 over the three sessions around the disclosure (2 Aug 2022 to 5 Aug 2022). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Initial data on bivalent booster mRNA-1273.214
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Moderna? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-MRNA-006183 · Corrections policy